Longeveron (LGVN) Free Cash Flow (2020 - 2026)

Longeveron's (LGVN) quarterly Free Cash Flow came in at -$4.4 million in Q1 2026, up 7.49% year-on-year from -$4.1 million in Q1 2025, and up 17.48% quarter-over-quarter from -$5.3 million in Q4 2025.

Longeveron (LGVN) Free Cash Flow (2020 - 2026) Analysis & Trends

Longeveron's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$4.4 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 7.49% year-over-year to -$4.4 million in Q1 2026; TTM through Mar 2026 was -$18.5 million, a 14.81% decrease from a year earlier, with the FY2025 full-year figure at -$18.9 million, down 30.07% from the prior year.
  • Free Cash Flow advanced to -$4.4 million in Q1 2026 per LGVN's latest filing, from -$5.3 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$2.4 million in Q4 2022 and bottomed at -$5.9 million in Q1 2023.
  • The 5-year median for Free Cash Flow is -$4.4 million (2026), against an average of -$4.2 million.
  • Across the five-year window, Free Cash Flow slumped 94.52% in 2022 and soared 47.33% in 2024, its largest moves.
  • Year by year, Free Cash Flow stood at -$2.4 million in 2022, then plunged by 75.27% to -$4.2 million in 2023, then rose by 18.63% to -$3.4 million in 2024, then tumbled by 56.41% to -$5.3 million in 2025, then rose by 17.48% to -$4.4 million in 2026.
  • Per Business Quant, the three latest LGVN Free Cash Flow figures stand at -$4.4 million (Q1 2026), -$5.3 million (Q4 2025), and -$5.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 158.09 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.29 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 848.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.95 Mn
10 Longeveron 3.97 Mn -11.79 Mn 264,000.00 -4.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.37 Mn
Mar 31, 2026 -4.37 Mn
Dec 31, 2025 -5.30 Mn
Dec 31, 2025 -5.30 Mn
Sep 30, 2025 -5.11 Mn
Sep 30, 2025 -5.11 Mn
Jun 30, 2025 -3.76 Mn
Jun 30, 2025 -3.76 Mn
Mar 31, 2025 -4.72 Mn
Mar 31, 2025 -4.72 Mn
Dec 31, 2024 -3.39 Mn
Dec 31, 2024 -3.39 Mn
Sep 30, 2024 -3.27 Mn
Sep 30, 2024 -3.27 Mn
Jun 30, 2024 -4.76 Mn
Jun 30, 2024 -4.76 Mn
Mar 31, 2024 -3.10 Mn
Mar 31, 2024 -3.10 Mn
Dec 31, 2023 -4.16 Mn
Dec 31, 2023 -4.16 Mn